NCT00295022View on ClinicalTrials.gov

Compare the Efficacy of Levocetirizine and Montelukast to Placebo in Reducing Seasonal Allergic Rhinitis (SAR) Symptoms in Ragweed Sensitive Subjects

PHASE4CompletedINTERVENTIONAL

Enrollment

418

Participants

Timeline

Start Date

July 29, 2006

Primary Completion Date

October 1, 2006

Study Completion Date

October 1, 2006

Conditions

Rhinitis, Allergic, Seasonal

Interventions

DRUG

Placebo

"* Pharmaceutical form: Over-encapsulated tablet~* Route of administration: Oral use"

DRUG

Montelukast

"* Pharmaceutical form: Over-encapsulated tablet~* Concentration: 10 mg~* Route of administration: Oral use"

DRUG

Levocetirizine

"* Pharmaceutical form: Over-encapsulated tablet~* Concentration: 5 mg~* Route of administration: Oral use"

Trial Locations (1)

Unknown

Kingston

All Listed Sponsors

lead

UCB S.A. - Pharma Sector

INDUSTRY

NCT00295022 - Compare the Efficacy of Levocetirizine and Montelukast to Placebo in Reducing Seasonal Allergic Rhinitis (SAR) Symptoms in Ragweed Sensitive Subjects | Biotech Hunter | Biotech Hunter